文献速递神经创伤神经重症

创伤性脑损伤后静脉血栓栓塞早期药物预防的安全性:系统综述与Meta分析——军事创伤性脑损伤计划研究

Safety of early chemoprophylaxis for venous thromboembolism after traumatic brain injury: a systematic review and meta-analysis. A military traumatic brain injury initiative study.
PubMed 文献 · J Neurosurg · 2024-11-22

该系统综述与Meta分析检索至2023年1月的英文文献,纳入30项住院创伤性脑损伤患者静脉血栓栓塞药物预防研究。药物预防组CT证实的颅内出血进展风险为7.0%(95%CI 4.0%-10.0%);早期与晚期预防组颅内出血进展无差异(12项研究;OR 0.79[95%CI 0.56-1.12]);预防组与未预防组亦无显著差异(5项研究;OR 0.57[95%CI 0.28-1.18])。作者认为多数作者视伤后72小时药物预防为安全,但48小时或24小时时间点仅少量低质量研究。

要点

  • 药物预防组CT证实的颅内出血进展风险为7.0%(95%CI 4.0%-10.0%)。
  • 早期与晚期预防组颅内出血进展无差异(12项研究;OR 0.79[95%CI 0.56-1.12])。
  • 预防组与未预防组颅内出血进展无显著差异(5项研究;OR 0.57[95%CI 0.28-1.18])。

核心结论

  • 文献综述显示多数作者认为创伤性脑损伤后72小时行静脉血栓栓塞药物预防是安全的。
  • 本Meta分析未发现伤后72小时内早期开始药物预防增加颅内出血风险的证据。
  • 作者强调仅少量低质量研究涉及48小时或24小时时间点,下一步应开展随机非劣效性试验。

研究设计与样本

  • 系统综述与Meta分析,检索英文文献自数据库建库至2023年1月。
  • 两位独立评审者筛选住院创伤性脑损伤患者静脉血栓栓塞药物预防的研究。
  • 共30项研究符合纳入标准。
  • 研究参数包括颅内出血进展(开始药物预防后随访影像判定)与药物预防使用与否、时机及类型的关系。

主要发现

  • 药物预防组CT证实的颅内出血进展风险为7.0%(95%CI 4.0%-10.0%)。
  • 早期与晚期静脉血栓栓塞预防组颅内出血进展无差异(12项研究;OR 0.79[95%CI 0.56-1.12])。
  • 药物预防组与未预防组CT证实的颅内出血进展无显著差异(5项研究;OR 0.57[95%CI 0.28-1.18])。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者强调仅少量低质量研究涉及48小时或24小时时间点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There is continuing uncertainty about the safety of early chemoprophylaxis for venous thromboembolism (VTE) in patients with traumatic brain injury (TBI). The objective of this paper was to 1) calculate the risk of progression of posttraumatic intracranial hemorrhage (ICH) after VTE chemoprophylaxis, and 2) compare the probability of ICH progression in early versus late VTE prophylaxis. METHODS: The authors searched for English-language literature from database inception to January 2023. Two independent reviewers selected studies on post-TBI VTE chemoprophylaxis in hospitalized patients. Study parameters included ICH progression (as determined by follow-up imaging after starting chemoprophylaxis) in relation to use versus nonuse, timing, and type of VTE chemoprophylaxis. Pertinent variables included author, year, study type, demographic variables, cranial and systemic Injury Severity Scores, and data documenting ICH progression or indirect evidence of TBI worsening after the initiation of VTE chemoprophylaxis. RESULTS: Thirty studies fulfilled the inclusion criteria. There was a 7.0% (95% CI 4.0%-10.0%) risk of CT-documented ICH progression following VTE chemoprophylaxis in the prophylactically treated group. There was no difference between the early versus late VTE prophylaxis groups for ICH progression (12 studies; OR 0.79 [95% CI 0.56-1.12]). There was also no significant difference in CT-documented ICH progression between the prophylactically treated and nontreated groups (5 studies; OR 0.57 [95% CI 0.28-1.18]). CONCLUSIONS: The review of the literature shows that VTE chemoprophylaxis 72 hours after TBI is considered safe by the majority of authors. This meta-analysis did not reveal any evidence of increased risk of ICH when starting VTE chemoprophylaxis earlier, i.e., within 72 hours of TBI; however, it is important to emphasize that only a small number of lower-quality studies addressed the 48-hour or 24-hour time point. A randomized noninferiority trial should be the next step in answering the question of early (within 72 hours) VTE chemoprophylaxis after TBI.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Dengler BA, Haight T, Fu A, et al. Safety of early chemoprophylaxis for venous thromboembolism after traumatic brain injury: a systematic review and meta-analysis. A military traumatic brain injury initiative study. J Neurosurg. 2024. PMID: 39576983. doi:10.3171/2024.7.JNS232697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。